Sirona Biochem Corp
- LAST PRICE0.0450
- TODAY'S CHANGE (%)-0.0150 (-25.0000%)
- Bid / Lots0.0450/ 10
- Ask / Lots0.0500/ 25
- Open / Previous Close0.0550 / 0.0600
- Day Range
- 52 Week Range
- Volume139,012
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SBM |
|---|---|---|
| 10:10 ET | 35000 | 0.06 |
| 10:15 ET | 59000 | 0.04 |
| 10:24 ET | 45000 | 0.045 |
Jun 18, 2024
GlycoProteMim Featured in Stonegate Healthcare's Latest Anti-Aging Research Report, from 10:35AM ET on Tuesday Jun 18, 2024 by Dow Jones
10:35AM ET on Tuesday Jun 18, 2024 by Dow JonesStonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations, from 8:51AM ET on Tuesday Jun 18, 2024 by Dow Jones
8:51AM ET on Tuesday Jun 18, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sirona Biochem Corp | 11.6M | -4.9x | --- |
Biovaxys Technology Corp | 15.4M | -0.6x | --- |
Telo Genomics Corp | 14.2M | -4.4x | --- |
FSD Pharma Inc | 8.9M | -0.5x | --- |
Willow Biosciences Inc | 15.3M | -1.4x | --- |
Kane Biotech Inc | 19.1M | -3.8x | --- |
Company Information
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).
Contact Information
- Headquarters
- c/o WeWork, 595 Burrard St.VANCOUVER, BC, Canada V7X 1L4
- Phone
- 604-641-4466
- Fax
- 604-608-5471
Executives
- Chairman of the Board, Chief Executive Officer, Founder
- Howard Y
- Chief Financial Officer, Director
- Christopher Hopton
- Chief Scientific Officer, Director
- Geraldine Deliencourt-Godefroy
- Independent Director
- Alex Marazzi
- Independent Director
- Jason Tian
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.6M |
|---|---|
Revenue (TTM) | $-12.1K |
Shares Outstanding | 257.0M |
Sirona Biochem Corp does not pay a dividend. | |
Beta | -0.12 |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
